Clinical research is a critical factor in our ability to improve care for cancer patients. Not only are new treatments discovered and validated, but patients entered into clinical trials have, as a group, been show to experience better outcomes in terms of the management of their conditions. This is why we subscribe to the National Cancer Institute's view that, whenever possible, a patient's best cancer treatment option is a clinical trial. We encourage patients to discuss this option with their physician.
The Baystate Regional Cancer Program has an active clinical research program, including affiliations with National Cancer Institute-sponsored cooperative research organizations such as the Eastern Cooperative Oncology Group (ECOG), the National Surgical Adjuvant Bowel and Breast Project (NSABP), the Children's Oncology Group (COG), the Gynecologic Oncology Group, and the Radiation Therapy Oncology Group (RTOG). In addition, clinical trials of new cancer agents and novel approaches to cancer care being investigated by Baystate's own physicians are available.
Our research efforts do not include just prospective clinical trials. We also conduct research into our past performance through our active tumor registry. In this way, we continue to monitor our own quality and ensure the best possible outcomes for future patients.
For information regarding current research protocols being conducted through the Baystate Regional Cancer Program, please contact the Oncology Research Office at 413-794-3736.